🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

TG Therapeutics, Inc.

TGTX Healthcare
$63.34 $-1.54 (-2.37%)
Market Cap: $8.87 B
Gurus Holding
7
Popularity Rank
#1075
% of Shares Held
1.44%
Net Activity (Q3 2026)
+$547,500.39

Guru Ownership Trend

Guru Analysis for TG Therapeutics, Inc. (TGTX)

TG Therapeutics, Inc. (TGTX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $127.7 M.

Top institutional holders include Ray Dalio and Steven Cohen.

Institutional sentiment is currently Bullish. This is evidenced by a $547,500.39 net inflow during the quarter.

Recent activity highlights Larry Robbins who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 33.9%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$19.4 M
Total Buy Value
New Buys 1
Additions 2
-$18.85 M
Total Sell Value
Reductions 3
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
4
Net Buyers
3

FAQs for TG Therapeutics, Inc. (TGTX)

Major holders include Ray Dalio ($32.72 M), Steven Cohen ($25.17 M), Renaissance Technologies (RenTech) ($25.05 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 2.02 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $547,500.39, with 3 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited TGTX. The total reported sell value was $18.85 M.

Yes, 1 managers opened new positions in TGTX, and 2 increased their existing holdings. The total reported buy value was $19.4 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.14% Add 36.5% 586,631 $32.72 M Q3 2026
0.03% Add 70.3% 451,269 $25.17 M Q3 2026
0.03% Reduce -33.9% 449,000 $25.05 M Q3 2026
0.01% Reduce -3.3% 427,638 $23.85 M Q3 2026
0.62% 52,500 $2.93 M Q3 2026
0.00% Reduce -1.3% 44,342 $2.47 M Q3 2026
0.00% New Buy 4,800 $267,744 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form